Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$89,088
in 5 filings, $89K under 10b5-1 plans

Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 4 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Purchase +1,000,000 2,709,401
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Purchase +20,407 2,729,808
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Conversion +1,709,401 1,709,401
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Purchase +256,986 256,986
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Purchase +15,072 15,072
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Purchase +481,567 481,567
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Purchase +261,447 261,447
2015-02-08 VIKING GLOBAL INVESTORS LP 10% owner Purchase +5,335 266,782

Page 30 of 30 · 588 trades